Burden of Psoraisis image

Click here to view survey results

Discovery video image

Innovative Drug Discovery Speeds New Treatments to Patients (video)

Dr. Mark Fishman, president of the Novartis Institutes of BioMedical Research (NIBR), talks about the search for new drugs to address unmet medical needs.

Group image CPD

Community Partnership Day 2015

Novartis staff in Ireland, donated almost 2,000 volunteering hours. Click here to read more.


Novartis sponsors the patient pillar of the newly established National Institute of Preventative Cardiology (NIPC)

February 2015, Novartis Ireland is proud to sponsor the patient pillar of the National Institute of Preventative Cardiology (NIPC). The NIPC was established by the Croí Cardiac Foundation and is an affiliate of the National University of Ireland, Galway (NUIG). Click here to read more.

Annual results

Novartis final results 2014


Visit the event centre

Read the press release

Download the annual report

New Report on Psoriasis

Survey reveals that more than half of people in Ireland with psoriasis have been the target of unpleasant comments about their skin

Burden of Psoraisis group image

Click here to find out more and read the report


Life is Calling

Inspiring People With Every Breath


COPD: Life is Calling is a new global online community, aiming to inspire and challenge people living with chronic obstructive pulmonary disease (COPD) to set themselves a goal that could help them get back an aspect of their life that they thought they had lost. Join us at www.copdlifeiscalling.com and take part by sharing your personal challenge and receive the support of our community with tips, tools and stories to help you live life to the fullest. >>

COPD laughing v2

Novartis Pharmaceuticals and Alcon sponsor XOVA awards providing grant funding up to EUR 50,000 for non-profit programs in ophthalmology

Click here to find out more

Fighting blindness ball

Novartis present the Fighting Blindness Empower Award to Áine Lennon

The Fighting Blindness Empowerment Award, sponsored by Novartis, is a special honour given to those who help the charity Fighting Blindness with its mission to cure, support and empower people affected by sight loss.  The award was presented to Áine Lennon from County Carlow. >>



First of its kind disease tracking and management resource launched for people with MS

Research shows that substantial numbers of people with MS currently do not record important symptom changes, despite the potential impact on their disease >>

AMD Week

Almost 400 people received a free AMD eye test from the Novartis mobile testing unit during AMD Awareness Week.

AMD (Age-Related Macular Degeneration) is the leading cause of blindness in Ireland and affects one in ten people over 50 with 7,000 new cases diagnosed each year.  The AMD Awareness Campaign, which is supported by Fighting Blindness, NCBI: the National Sight Loss Organisation, the Irish College of Ophthalmologists, the Association of Optometrists Ireland and Novartis Ireland, highlights the importance of regular eye testing and the benefits of early diagnosis and treatment by encouraging more conversation about AMD >>


Novartis Supported the IICN Neuroscience Fellowship 2014

In the last 3 years Novartis Ireland in conjunction with the Irish Institute of Clinical Neuroscience have supported a one year fellowship grant in Clinical Neuroscience. The fellowship aims to provide outstanding neuroscientists, who should have the potential to become leaders in their chosen field, with the opportunity to conduct a significant research project and all applications are peer reviewed >>

DME Week

Eye Health Campaign Highlights Leading Cause of Blindness in Diabetes

Celebrity chef, Andrew Rudd joined Diabetes Ireland, NCBI-the National Sight Loss Agency, Fighting Blindness, the Irish College of Ophthalmologists (ICO), the Association of Optometrists Ireland (AOI) and Novartis to support Eye Am What I Eat campaign.  The campaign aimed to raise awareness of diabetic macular edema (DME) a form of diabetic retinopathy that can have a severe effect on vision, causing significant sight loss >>

LCZ- image

New analyses show Novartis’ LCZ696 could change course of heart failure for patients

New data from PARADIGM-HF shows LCZ696 cut the incidence of sudden deaths, emergency room visits, hospitalizations, worsening symptoms and need for more intense treatment in HFrEF patients versus enalapril. >>

Cleveland Clinic

LCZ696 was recognised in Cleveland Clinic's Top 10 Medical Innovators for 2015



On Wednesday, October 29, the Cleveland Clinic announced its 9th annual list of Top 10 Medical Innovations that are likely to have a major impact on improving patient care in 2015. For the second year running Novartis’ Cardio Metabolic medicines made the list, with LCZ696 following serelaxin last year. >>



LCZ- image

LCZ696 new heart failure medicine cuts cardiovascular deaths by 20%

Novartis’ new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial >>

World Uticaria Day

World Urticaria Awareness Day October 1st 2014. Click here for more information.

Google lens

Novartis to license Google "smart lens" technology

Novartis announced that its eye care division Alcon has entered into an agreement with a division of Google Inc. to in-license its “smart lens” technology for all ocular medical uses. The agreement with Google[x], a team within Google that is devoted to finding new solutions to big global problems, provides Alcon with the opportunity to develop and commercialize Google’s “smart lens” technology with the potential to transform eye care and further enhance Alcon’s pipeline and global leadership in contact lenses and intraocular lenses. The transaction remains subject to anti-trust approvals. >>

ICORG infographic

Novartis Ireland participates in International Clinical Trials Day

Novartis, in conjunction with ICORG (The All-Ireland Cooperative Oncology Research Group) and a number of pharmaceutical companies, mark International Clinical Trials Day. This day is celebrated worldwide to commemorate when James Lind began the first known trial comparing different treatments for scurvy, in 1747. >>

GSK Integration pipeline




Related Links:


Skin to live in 

The sight experience


dont forget.ie


Irish skin foundation


 Living like you


COPD Support Ireland logo2



Top Links:

Contact us

Report an Adverse Event